Ramdev may face trouble on his putrajeevak medicine

Ramdev has defended the medicine saying it has nothing to do with the birth of a son or daughter

Ramdev may face trouble on his putrajeevak medicine
Shishir Prashant Dehradun
Last Updated : Jan 30 2016 | 12:50 AM IST
Yoga guru Baba Ramdev may run into trouble in Uttarakhand after an inquiry by the state Director General (DG) Health and law department gave a negative report against him on his controversial putrajeevak beej medicine which allegedly promises a male child.

Principal Secretary Health Om Prakash confirmed the development and said the report against Ramdev has been sent to Chief Minister Harish Rawat. "I can only say that the inquiry report on Putrajeevak medicine was against Ramdev. We have sent the report to the Chief Minister," Prakash said. He refused to give more details.

Both the DG Health and Law department had "closely scrutinized" the putrajeevak beej medicine issue which had stirred a controversy last year after Janata Dal (United) MP K C Tyagi in the Rajya Sabha had sought an action against Ramdev for allegedly promising male child.

Immediately after the controversy, the Centre had directed the Uttarakhand government to hold inquiry into the issue. Initially, the government had set up a three member committee headed by Drug Controller Ayush P D Chamoli to submit a report. The Chamoli committee however had given a clean chit to Ramdev claiming his medicine name was in accordance to the ayurvedic books and ancient literature.

Interestingly, Ramdev had also defended the medicine saying it has nothing to do with the birth of a son or a daughter. "The botanical name of the medicine is putrajeeva roxburghi. It is called putrajeevak in Hindi, Marathi, Gujarati and other languages," Ramdev had stated while defending his medicine.

But, after the Chamoli committee report, the state government asked the D G Health and state law department to give report on the issue which in turn gave a negative report, said Prakash.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 30 2016 | 12:42 AM IST

Next Story